“The Canadian HIV/AIDS Legal Network welcomes this opportunity to provide submissions to the House of Commons Standing Committee on International Trade on the subject of the Trans-Pacific Partnership (TPP).”
In the brief The Trans-Pacific Partnership: Trading Away Access to Affordable Medicines, we “set out […] a number of specific concerns about how provisions in the TPP will undermine equitable access to affordable medicines, particularly:
(i) the stricter rules on intellectual property protection;
(ii) the deal’s impact on drug formulary prices and weakening of controls on drug company marketing; and
(iii) the expanded rules for corporations to sue governments for regulating in the public interest under the investor-state dispute settlement clause.”